Glioblastoma multiforme: an updated overview of temozolomide resistance mechanisms and strategies to overcome resistance

Abstract Glioblastoma (GBM) is an aggressive primary brain tumor with high lethality. The typical treatment regimen includes post-surgical radiotherapy and temozolomide (TMZ) chemotherapy, which helps extend survival. Nevertheless, TMZ resistance occurs in approximately 50% of patients. This resista...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianlin Pu, Kai Yuan, Jian Tao, Yuliang Qin, Yongxin Li, Jing Fu, Zhong Li, Haimei Zhou, Zhengxiu Tang, Li Li, Xuesong Gai, Dongdong Qin
Format: Article
Language:English
Published: Springer 2025-05-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-02567-3
Tags: Add Tag
No Tags, Be the first to tag this record!